Cue Biopharma announces common stock, warrant offering, no amount given

Cue Biopharma announced that it is commencing an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of common stock. Oppenheimer & Co. is acting as sole book-running manager for the offering. Newbridge Securities Corporation is acting as co-manager for the offering.